SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
29-Aug-24 7:36 PM View: | Soleno Therapeutics Inc (SLNO) | 29-Aug-24 | Sale | 100,000 | $47.22 | $4,722,000.00 | (2%) 6.39M to 6.29M | |
29-Aug-24 7:36 PM View: | Soleno Therapeutics Inc (SLNO) | 28-Aug-24 | Sale | 425,000 | $47.35 | $20,123,800.00 | (6%) 6.82M to 6.39M | |
29-Aug-24 7:36 PM View: | Soleno Therapeutics Inc (SLNO) | 27-Aug-24 | Private Sale | 500,000 | $48.73 | $24,365,000.00 | (7%) 7.32M to 6.82M | |
01-May-24 1:10 PM View: | Soleno Therapeutics Inc (SLNO) | 30-Apr-24 | Sale | 351,242 | $45.13 | $15,851,600.00 | (5%) 7.67M to 7.32M | |
01-May-24 1:10 PM View: | Soleno Therapeutics Inc (SLNO) | 29-Apr-24 | Private Sale | 750,000 | $47.80 | $35,850,000.00 | (9%) 8.42M to 7.67M | |
03-Apr-24 8:47 PM View: | Terns Pharmaceuticals, Inc. (TERN) | 03-Apr-24 | Sale (Planned) | 138,066 | $6.20 | $856,009.00 | (2%) 6.38M to 6.24M | |
03-Apr-24 8:47 PM View: | Terns Pharmaceuticals, Inc. (TERN) | 02-Apr-24 | Sale (Planned) | 101,480 | $6.65 | $674,842.00 | (2%) 6.48M to 6.38M | |
03-Apr-24 8:47 PM View: | Terns Pharmaceuticals, Inc. (TERN) | 01-Apr-24 | Private Sale (Planned) | 181,117 | $6.99 | $1,266,010.00 | (3%) 6.66M to 6.48M | |
04-Oct-23 4:30 PM View: | Soleno Therapeutics Inc (SLNO) | 02-Oct-23 | Exercise (in-the money or at-the-money) | 5,215,000 | $2.50 | $13,037,500.00 | 163% 3.2M to 8.42M | |
28-Sep-23 5:00 PM View: | Soleno Therapeutics Inc (SLNO) | 26-Sep-23 | Exercise (in-the money or at-the-money) | 3,203,090 | $1.75 | $5,605,410.00 | 100% 0 to 3.2M | |
23-Dec-22 5:48 PM View: | Terns Pharmaceuticals, Inc. (TERN) | 23-Dec-22 | Purchase Duplicate | 758,620 | $7.25 | $5,500,000.00 | 13% 5.9M to 6.66M | |
08-Sep-22 8:00 PM View: | Terns Pharmaceuticals, Inc. (TERN) | 07-Sep-22 | Private Purchase Duplicate | 600,000 | $3.60 | $2,160,000.00 | 11% 5.3M to 5.9M | |
16-Aug-22 8:44 PM View: | Terns Pharmaceuticals, Inc. (TERN) | 16-Aug-22 | Purchase Duplicate | 1,500,000 | $2.42 | $3,630,000.00 | 28% 5.28M to 6.78M | |
16-Aug-22 8:44 PM View: | Terns Pharmaceuticals, Inc. (TERN) | 15-Aug-22 | Purchase Duplicate | 1,218 | $2.99 | $3,641.82 | < 1% 5.28M to 5.28M | |
16-Aug-22 8:44 PM View: | Terns Pharmaceuticals, Inc. (TERN) | 12-Aug-22 | Private Purchase Duplicate | 1,123,020 | $2.98 | $3,346,600.00 | 27% 4.16M to 5.28M | |
01-Jul-22 4:59 PM View: | Sierra Oncology, Inc. (SRRA) | 01-Jul-22 | Disposition | 3,329,510 | $55.00 | $183,123,008.00 | (100%) 3.33M to 0 | |
31-Jan-22 9:30 PM View: | Sierra Oncology, Inc. (SRRA) | 31-Jan-22 | Purchase Duplicate | 800,000 | $27.00 | $21,600,000.00 | 32% 2.53M to 3.33M | |
28-Jan-22 8:12 PM View: | Sierra Oncology, Inc. (SRRA) | 26-Jan-22 | Exercise (in-the money or at-the-money) | 612,437 | $13.20 | $8,084,170.00 | 32% 1.92M to 2.53M | |
31-Jan-20 8:00 PM View: | Sierra Oncology, Inc. (SRRA) | 29-Jan-20 | Conversion | 1,856,120 | -- | -- | 3045% 60.95K to 1.92M |